Deer Consumer Products (DEER) Announces Record First Quarter Financial Results
Deer Consumer Products, Inc. today announced record financial results for the first quarter ended March 31, 2012. The company is…
Blog
TherapeuticsMD (TXMD) Launches Third Prescription Prenatal Vitamin
VitaMedMD™ RediChew™ Rxchewable prenatal vitamin contains company’s patented folate developed to further reduce impact of folic acid-related deficiencies. TherapeuticsMD™ Inc.,…
Pershing Gold Corp. (PGLC) Phase I Drilling Discovery at Relief Canyon Significantly Increases Overall Mineralization Profile
Pershing Gold, the up and coming, Nevada-focused (Pershing County) precious metals developer, which has already established a solid acreage position…
International Stem Cell Corp. (ISCO) Announces New Stem Cell Manufacturing Technologies
International Stem Cell Corp., developer of therapeutic applications of human parthenogenetic stem cells (hpSCs) and cell-based research and cosmetic products,…
EnerNOC e (ENOC) Awarded Seven-Year Contract with San Francisco PUC
EnerNOC Inc. is a leading provider of energy efficient solutions, for reducing electricity demand, for commercial, industrial and institutional energy…
Mitel (MITL) Introduces New Cloud Based Service as the Next Stage in the Evolution of UCaas
Yesterday at Interop® 2012, Mitel, a leading provider of Unified Communications and Collaboration software solutions, announced their new approach for…
Keep Up With Your MBA Friend – Reference Book Review
There is a lot of knowledge that goes into the MBA programs at the top business schools in the United…
UNR Holdings, Inc. (UNRH) Completes 3 Phases of Marshal Rybalko Project in Moscow
UNR Holdings, a commercial and real estate development company operating primarily in Moscow and its surrounding suburban communities, today announced…
ImmunoCellular Therapeutics Ltd. (IMUC) Updates on Clinical Activity and Patient Enrollment for Study of Brain Cancer Vaccine Candidate
ImmunoCellular Therapeutics, a biotech company focused on the development of novel immune-based cancer therapies, today issued an update on clinical…
Complete Genomics (GNOM) Sequences Genomes in Type 2 Diabetes Genetic Study
Complete Genomics Inc. is whole human genome sequencing company that has developed and commercialized an innovative DNA sequencing service. The…